These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Expression of adiponectin in choroidal tissue and inhibition of laser induced choroidal neovascularization by adiponectin. Bora PS; Kaliappan S; Lyzogubov VV; Tytarenko RG; Thotakura S; Viswanathan T; Bora NS FEBS Lett; 2007 May; 581(10):1977-82. PubMed ID: 17466298 [TBL] [Abstract][Full Text] [Related]
8. Neovascular age-related macular degeneration: intraocular cytokines and growth factors and the influence of therapy with ranibizumab. Funk M; Karl D; Georgopoulos M; Benesch T; Sacu S; Polak K; Zlabinger GJ; Schmidt-Erfurth U Ophthalmology; 2009 Dec; 116(12):2393-9. PubMed ID: 19815292 [TBL] [Abstract][Full Text] [Related]
9. A value-based medicine analysis of ranibizumab for the treatment of subfoveal neovascular macular degeneration. Brown MM; Brown GC; Brown HC; Peet J Ophthalmology; 2008 Jun; 115(6):1039-1045.e5. PubMed ID: 17976724 [TBL] [Abstract][Full Text] [Related]
10. Angiogenesis inhibition and choroidal neovascularization suppression by sustained delivery of an integrin antagonist, EMD478761. Fu Y; Ponce ML; Thill M; Yuan P; Wang NS; Csaky KG Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5184-90. PubMed ID: 17962472 [TBL] [Abstract][Full Text] [Related]
11. Vascular targeting of ocular neovascularization with a vascular endothelial growth factor121/gelonin chimeric protein. Akiyama H; Mohamedali KA; E Silva RL; Kachi S; Shen J; Hatara C; Umeda N; Hackett SF; Aslam S; Krause M; Lai H; Rosenblum MG; Campochiaro PA Mol Pharmacol; 2005 Dec; 68(6):1543-50. PubMed ID: 16150930 [TBL] [Abstract][Full Text] [Related]
12. Suppression of choroidal neovascularization by inhibiting angiotensin-converting enzyme: minimal role of bradykinin. Nagai N; Oike Y; Izumi-Nagai K; Koto T; Satofuka S; Shinoda H; Noda K; Ozawa Y; Inoue M; Tsubota K; Ishida S Invest Ophthalmol Vis Sci; 2007 May; 48(5):2321-6. PubMed ID: 17460297 [TBL] [Abstract][Full Text] [Related]
13. Intravitreal human complement factor H in a rat model of laser-induced choroidal neovascularisation. Kim SJ; Kim J; Lee J; Cho SY; Kang HJ; Kim KY; Jin DK Br J Ophthalmol; 2013 Mar; 97(3):367-70. PubMed ID: 23258212 [TBL] [Abstract][Full Text] [Related]
16. Antiangiogenic effects of bisphosphonates on laser-induced choroidal neovascularization in mice. Nagai T; Imai H; Honda S; Negi A Invest Ophthalmol Vis Sci; 2007 Dec; 48(12):5716-21. PubMed ID: 18055824 [TBL] [Abstract][Full Text] [Related]
17. Inhibitory effect of YC-1, 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole, on experimental choroidal neovascularization in rat. Song SJ; Chung H; Yu HG Ophthalmic Res; 2008; 40(1):35-40. PubMed ID: 18032914 [TBL] [Abstract][Full Text] [Related]
18. A 1-year retrospective review of ranibizumab for naive nonsubfoveal choroidal neovascularization secondary to age-related macular degeneration. Arias L; Ruiz-Moreno JM; Gómez-Ulla F; Fernández M; Montero J Retina; 2009; 29(10):1444-9. PubMed ID: 19730163 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of VEGF secretion and experimental choroidal neovascularization by picropodophyllin (PPP), an inhibitor of the insulin-like growth factor-1 receptor. Economou MA; Wu J; Vasilcanu D; Rosengren L; All-Ericsson C; van der Ploeg I; Menu E; Girnita L; Axelson M; Larsson O; Seregard S; Kvanta A Invest Ophthalmol Vis Sci; 2008 Jun; 49(6):2620-6. PubMed ID: 18515591 [TBL] [Abstract][Full Text] [Related]